Medical - Biomedical and Genetics
Industry Rank
More Info
The Zacks Industry Rank assigns a rating to each of the 253 X (Expanded) Industries based on their average Zacks Rank.
An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.
The industry with the best average Zacks Rank would be considered the top industry (1 out of 253), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (253 out of 253) would place in the bottom 1%.
Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank
The Zacks Industry Rank assigns a rating to each of the 253 X (Expanded) Industries based on their average Zacks Rank.
An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.
The industry with the best average Zacks Rank would be considered the top industry (1 out of 253), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (253 out of 253) would place in the bottom 1%.
Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank
+3.28%
YTD Return More Info
Year to Date (YTD) Return shows the median percentage price change for the respective equally-weighted Industry since the beginning of the year.
Updated Feb 26
Sector: Medical
Performance
| Total Return % | IVV(iShares-SP500) | |
|---|---|---|
| 1 Month | -5.28 | -0.91 |
| 3 Months | 7.82 | NA |
| YTD | 3.28 | NA |
| 1 Year | 9.61 | 23.89 |
| 3 Years | -12.26 | 43.03 |
| 5 Years | -9.60 | 108.84 |
Medical - Biomedical and Genetics Performance
Key Metrics for
Industry Earnings
| Industry | IVV(iShares-SP500) | |
|---|---|---|
| PE (F1) | 28.48 | 20.41 |
| PEG (Ratio) | 1.31 | 2.32 |
| Proj EPS Growth | 9.14% | 11.42% |
| Hist EPS Growth | 18.91% | 9.34% |
| Net Margin | -181.91% | 10.59% |
| Hist Sales Growth | 17.35% | 5.39% |
| Hist Dividend Growth | 0.00% | 0.00% |
Financial Ratios
| Industry | IVV(iShares-SP500) | |
|---|---|---|
| Beta | 1.33 | 1.07 |
| ROE | -59.26 | 14.65 |
| ROA | -43.78 | 5.75 |
| ROI | -53.50 | 9.07 |
| Debt-to-Equity | 0.00 | 0.68 |
| Current Ratio | 6.21 | 1.39 |
| Cash Flow ($/share) | -24.41 | 1,731.40 |
| Price to Book | 4.71 | 0.00 |
| Price To Sales | 21.26 | 3.10 |
| Dividend Yield | 0.00% | 1.48% |